摘要
目的宫颈腺癌是宫颈癌中仅次于鳞癌的常见病理类型,预后较差,本研究旨在探讨宫颈腺癌预后的相关因素及治疗方法。方法回顾性分析南通市肿瘤医院1980年1月至2000年12月间所收治的76例宫颈腺癌的临床病理资料。结果按FIGO分期Ⅰ期、Ⅱ期、Ⅲ期患者5年生存率分别为66.67%、47.06%、19.44%。肿瘤大小与预后相关,而病理类型及治疗方法与预后无明显关系。结论宫颈腺癌发病率上升,预后较鳞癌差。临床分期和肿瘤大小是预后相关因素。
Objective The prognosis of patients with adenocarcinoma is not as good as squamous cell carcinoma. To determine the prognostic factors and the treatment modality of adenocarcinoma. Methods A total of 76 cases with primary adenocarcinoma were studied retrospectively. Clinical and pathological data were reviewd and analyzed. Results The 5-year survival rate for stages Ⅰ , Ⅱ and Ⅲ was 66.67% , 47.06% ,19.44%. The tumor size was significant prognostic factor, while pathological subtype and treatment modality were not. Conclusions The incident of the adenocarcinoma subtype has increased in the world, and the patients with adenocarcinoma have a worse prognosis as compared with those with squamous carcinoma. FIGO stage and bulky tumors are significant prognostic factors for survival in cervical adenocarcinoma.
出处
《肿瘤基础与临床》
2007年第5期439-440,共2页
journal of basic and clinical oncology
关键词
宫颈癌
腺癌
治疗
预后
uterine cervix
adenocarcinoma
treatment
prognosis
